This project examines the physiological effects and the underlying biochemical mechanisms of the action of delta opioid peptide DADLE and a DADLE-related protein HIT (Hibernation Induction Trigger) in tissue survival. In this fiscal year, we found that both DADLE and HIT display similar biological activity in mouse vas deferens bioassay. Further, we have partially sequenced an alpha-1-glycoprotein-like 88 kDa hibernation-related protein in HIT, which may prove to be the blood- borne HIT molecule. The delta opioid peptide DADLE is also found to reverse the pre-existing neuronal damage induced by methamphetamine (METH). Specifically, a single injection of METH causes a long-term loss of dopamine transporters (DAT) in the striatum of CD-1 mouse. Two week after the injection of METH, 60% of DAT was destroyed. A single injection of DADLE, given at day 14 post METH administration, restores the DAT level close to that of controls at day 16. In a separate study examining the genomic effect exerted by METH in CD-1 mice, we found that the elevated level of the mRNA of an immediate early gene, c-fos, is alleviated by a DADLE pretreatment. Thus, our results indicate that DADLE can promote the neuronal survival against pre-existing insults and that this action of DADLE may involve influences at the genomic level. - opioid; myocardiac survival; ischemia; methamphetamine; neurotoxicity; hibernation induction protein; hibernation.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000263-06
Application #
6289603
Study Section
Special Emphasis Panel (CNRB)
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Tsai, Shang-Yi; Hayashi, Teruo; Su, Tsung-Ping (2005) Picomolar concentrations of hibernation induction delta opioid peptide [D-Ala2,D-Leu5]enkephalin increase the nerve growth factor in NG-108 cells. Synapse 57:179-81
Borlongan, Cesario V; Wang, Yun; Su, Tsung-Ping (2004) Delta opioid peptide (D-Ala 2, D-Leu 5) enkephalin: linking hibernation and neuroprotection. Front Biosci 9:3392-8
Wang, Yun; Chang, Chen-Fu; Morales, Marisela et al. (2003) Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. J Neurosci 23:7958-65
Hayashi, Teruo; Su, Tsung-Ping (2003) Chronic [D-Ala2, D-Leu5]enkephalin treatment increases the nerve growth factor in adult mouse brain. Eur J Pharmacol 464:237-9
Hayashi, Teruo; Tsao, Li-I; Su, Tsung-Ping (2002) Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala(2),D-Leu(5)]enkephalin in PC12 cells. Synapse 43:86-94
Bolling, S F; Badhwar, V; Schwartz, C F et al. (2001) Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists. J Thorac Cardiovasc Surg 122:476-81
Wang, Y; Hayashi, T; Chang, C F et al. (2001) Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. Stroke 32:775-82
Borlongan, C V; Zhou, F C; Hayashi, T et al. (2001) Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats. Neurobiol Dis 8:636-46
Borlongan, C V; Su, T P; Wang, Y (2001) Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells. Cell Transplant 10:53-8
Hayashi, T; Hirata, H; Asanuma, M et al. (2001) Delta opioid peptide [D-Ala2, D-Leu5]enkephalin causes a near complete blockade of the neuronal damage caused by a single high dose of methamphetamine: examining the role of p53. Synapse 39:305-12

Showing the most recent 10 out of 17 publications